Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    VXM01

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OSR Holdings To Showcase VXM01 License Deal At Emerging Growth
    OSR Holdings To Showcase VXM01 License Deal At Emerging Growth

    30 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-30/osr-holdings-to-present-vxm01-licensing-agreement-at-emerging-growth-conference-may-7-2026

    PHARMIWEB
    30 Apr 2026
    Share Share
    OSR Holdings Executes Definitive $815 Million Global License
    OSR Holdings Executes Definitive $815 Million Global License

    29 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-29/osr-holdings-executes-definitive-815-million-global-license-agreement-for-vxm01-with-bcm-europe

    PHARMIWEB
    29 Apr 2026
    Share Share
    OSR Holdings Updates Investors at EGC on April 15, 2023
    OSR Holdings Updates Investors at EGC on April 15, 2023

    30 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-30/osr-holdings-to-update-investors-at-the-emerging-growth-conference-on-april-1-2026

    PHARMIWEB
    30 Mar 2026
    Share Share
    OSR Holdings Updates $815M VXM01 Deal to Boost Parent Value
    OSR Holdings Updates $815M VXM01 Deal to Boost Parent Value

    23 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-23/osr-holdings-updates-815-million-vxm01-licensing-deal-structure-to-capture-value-at-parent-level

    PHARMIWEB
    23 Mar 2026
    Share Share
    CEO's Statement to Shareholders
    CEO's Statement to Shareholders

    02 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-02/ceo-statement-to-shareholders

    PHARMIWEB
    02 Feb 2026
    Share Share
    Vaximm AG Revises Term Sheet to Shorten BCM Europe Exclusivity
    Vaximm AG Revises Term Sheet to Shorten BCM Europe Exclusivity

    02 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vaximm-ag-an-osr-company-updates-term-sheet-with-bcm-europe-to-shorten-exclusivity-period-to-three-months-302630569.html

    PR NEWSWIRE
    02 Dec 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.